Results 51 to 60 of about 13,126,675 (165)

Immunological Effects of Amphotericin B Desoxycholate and Liposomal Amphotericin B on Splenocytes from Immune-Normal and Immune-Compromised Mice [PDF]

, 1992
Because of the increasing number of serious risk factors which predispose a normally immune competent host to infection, the incidence of systemic fungal infections is steadily increasing.
Schindler, Jay Jenson
core   +1 more source

Reported unfavourable maternal outcomes after liposomal amphotericin B and antimony treatment among those who were treated during pregnancy.

, 2021
Reported unfavourable maternal outcomes after liposomal amphotericin B and antimony treatment among those who were treated during pregnancy.
Fabiana Alves (217602), Eli Harriss (5636576), Prabin Dahal (3628118), Brittany J. Maguire (10492519), Philippe J. Guerin (7464971), Sauman Singh-Phulgenda (10312644), Piero L. Olliaro (9010184), Koert Ritmeijer (123652)   +7 more
core   +1 more source

Right Angle, Wrong Assumptions: A Case of Endobronchial Mucormycosis Presenting as a Pedunculated Mass Mimicking Malignancy

Respirology Case Reports, Volume 14, Issue 11, November 2026.
We report a case of endobronchial pulmonary mucormycosis presenting as a pedunculated endobronchial mass in a patient with poorly controlled Type 2 diabetes mellitus and chronic obstructive pulmonary disease. The lesion was initially suspected to be lung cancer, highlighting the importance of considering mucormycosis in the differential diagnosis of an
Rabbia Abbas, Ali Gohar, Hafiz Muhammad Faisal Nadeem, Memoona Anees, Nida Nazar, Muhammad Umais, Muhammad Husnain Ahmad   +6 more
wiley   +1 more source

Clinical Impact of Haemophagocytic Lymphohistiocytosis Among Patients With HIV/AIDS and Disseminated Histoplasmosis in a Hyperendemic Region of Northeastern Brazil

Mycoses, Volume 69, Issue 11, November 2026.
ABSTRACT Background Haemophagocytic lymphohistiocytosis (HLH) is a life‐threatening hyperinflammatory syndrome that may occur in people living with HIV/AIDS (PLWHA), often triggered by opportunistic infections such as disseminated histoplasmosis (DH).
Matheus Alves de Lima Mota, Marcos Maciel Sousa, João Victor Monteiro Souza, Italo Oliveira Moura, Jéssica Maria de Sousa Oliveira, Jacó Ricarte Lima de Mesquita, Lisandra Serra Damasceno, Terezinha do Menino Jesus Silva Leitão, Gdayllon Cavalcante Meneses, Elizabeth De Francesco Daher   +9 more
wiley   +1 more source

Proportion of patients achieving initial and definitive cure after treatment with amphotericin B emulsion and liposomal amphotericin B (mITT population).

, 2014
Data are n (%); mITT = modified Intent-to-Treat; CI = confidence interval.Proportion of patients achieving initial and definitive cure after treatment with amphotericin B emulsion and liposomal amphotericin B (mITT population).
Tara Kant Jha (631050), Shyam Sundar (58354), Chandra Shekhar Lal (631051), Deepak Verma (631052), Neena Verma (505159), Chandreshwar Prasad Thakur (631049), Pradeep Das (230639), Vidya Nand Ravi Das (567509), Shahnawaz Alam (631053), Krishna Pandey (567511)   +9 more
core   +1 more source

Clinical and laboratory evaluation of patients with visceral leishmaniasis undergoing different therapeutic regimens of liposomal amphotericin B

Acta Scientiarum. Health Sciences
Visceral Leishmaniasis (VL) is an infectious disease caused by protozoa of the Leishmania genus and is transmitted to humans by the bite of infected female Lutzomyia sandflies.
Fernanda Santana da Silva, Elder Andrade Oliveira Filho , Maria Luísa Santos Fernandes, Gabriel Donner Oliveira, Victor Hugo Dantas Guimarães   +4 more
doaj   +1 more source

Real‐World Use of Rezafungin for the Treatment of Challenging Aspergillus Infections

Mycoses, Volume 69, Issue 11, November 2026.
ABSTRACT Background Aspergillus infections can pose significant treatment challenges, due in part to increasing triazole resistance. Clinical insight is needed to understand the potential for rezafungin, a next‐generation echinocandin with once‐weekly dosing, to address some limitations of current treatments for Aspergillus infections.
Neil Stone, Pablo Bachiller‐Luque, Simone Giuliano, Sumita Pai, Berta Pernas, Carolina Garcia‐Vidal, Netta Tyler, Sara Ferin, Carlo Tascini, Ana Fernández Cruz   +9 more
wiley   +1 more source

Single-dose liposomal amphotericin B for visceral leishmaniasis in India

, 2010
Background: Some 50% of patients with visceral leishmaniasis (kala-azar) worldwide live in the Indian state of Bihar. Liposomal amphotericin B is an effective treatment when administered in short courses.
Chakravarty, Jaya, Rai, Madhukar, Murray, Henry W., Sundar, Shyam, Agarwal, Dipti, Dipti Agarwal, Henry W. Murray, Shyam Sundar, Jaya Chakravarty, Madhukar Rai   +9 more
core   +1 more source

Rhino‐Orbital Mucormycosis in an Immunocompetent Adult: A Case Report Emphasizing Diagnostic and Therapeutic Challenges

Clinical Case Reports, Volume 14, Issue 10, October 2026.
ABSTRACT Rhino‐orbital mucormycosis can present aggressively in immunocompetent adults, often with atypical initial symptoms that lead to misdiagnosis and dangerous delays. A high index of suspicion is paramount when facing a rapidly progressive orbital infection unresponsive to conventional therapy.
Seyed Mohammad Mousavi, Seyyed Amin Ayatollahi Mousavi, Omolbanin Faryabi, Iraj Sharifi, Hossein Kamyab, Zahra Shirazi   +5 more
wiley   +1 more source

Disseminated Blastomycosis With Pulmonary, Cutaneous, and Splenic Involvement in a Construction Worker: A Case Report

Clinical Case Reports, Volume 14, Issue 10, October 2026.
ABSTRACT Blastomycosis is a systemic fungal infection that is caused by Blastomyces dermatitidis or Blastomyces gilchristii. Although the lungs are the primary site of infection, blastomycosis can disseminate to the skin, bones, genitourinary system, and, rarely, visceral organs such as the spleen.
Toan N. Vu, Nilay Kumar
wiley   +1 more source